• Policy
• # of subjects in Phase 3 of SK's COVID vaccine is 93
• by Lee, Tak-Sun Aug 11, 2021 05:58am

• Company
• Changes after Pfizer and Moderna vaccines' full approval
• by Aug 11, 2021 05:58am

• Policy
• South Korea recovered Sartan products with AZBT impurities
• by Lee, Tak-Sun Aug 11, 2021 05:58am

• Policy
• Incentive-paid items for generic substitution fell to 12,757
• by Lee, Hye-Kyung Aug 11, 2021 05:58am

• Company
• Reimbursement for Kymriah will be deliberated by CDRC
• by Eo, Yun-Ho Aug 10, 2021 05:54am

• Policy
• Pfizer is working hard to introduce Prevenar-20 in Korea
• by Lee, Tak-Sun Aug 10, 2021 05:54am

• Company
• Marken establishs a cGMP cold-chain center in Korea
• by Nho, Byung Chul Aug 10, 2021 05:54am

• Policy
• Supply of Oseltamivir has declined 55% since COVID outbreak
• by Lee, Hye-Kyung Aug 10, 2021 05:54am

• Policy
• Vaccination agencies are expected to work too hard in Oct
• by Lee, Tak-Sun Aug 10, 2021 05:54am

• Opinion
• [FOCUS] Why retrieve the insurance paid for CA?
• by Chon, Seung-Hyun Aug 9, 2021 06:04am